Advanced search

The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals: the LIPI-GOAL trial.

(2001) ACTA CARDIOLOGICA. 56(2). p.109-114
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
MULS, E, Gui De Backer, C BROHET, and F HELLER. 2001. “The Efficacy of Atorvastatin in Treating Patients with Hypercholesterolaemia to Target LDL-cholesterol Goals: The LIPI-GOAL Trial.” Acta Cardiologica 56 (2): 109–114.
APA
MULS, E., De Backer, G., BROHET, C., & HELLER, F. (2001). The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals: the LIPI-GOAL trial. ACTA CARDIOLOGICA, 56(2), 109–114.
Vancouver
1.
MULS E, De Backer G, BROHET C, HELLER F. The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals: the LIPI-GOAL trial. ACTA CARDIOLOGICA. 2001;56(2):109–14.
MLA
MULS, E, Gui De Backer, C BROHET, et al. “The Efficacy of Atorvastatin in Treating Patients with Hypercholesterolaemia to Target LDL-cholesterol Goals: The LIPI-GOAL Trial.” ACTA CARDIOLOGICA 56.2 (2001): 109–114. Print.
@article{142329,
  author       = {MULS, E and De Backer, Gui and BROHET, C and HELLER, F},
  issn         = {0001-5385},
  journal      = {ACTA CARDIOLOGICA},
  language     = {eng},
  number       = {2},
  pages        = {109--114},
  title        = {The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals: the LIPI-GOAL trial.},
  volume       = {56},
  year         = {2001},
}

Web of Science
Times cited: